Van Cutsem E - Search Results

1

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis.

De Smedt L, Lemahieu J, Palmans S, Govaere O, Tousseyn T, Van Cutsem E, Prenen H, Tejpar S, Spaepen M, Matthijs G, Decaestecker C, Moles Lopez X, Demetter P, Salmon I, Sagaert X. De Smedt L, et al. Among authors: van cutsem e. Br J Cancer. 2015 Jul 28;113(3):500-9. doi: 10.1038/bjc.2015.213. Epub 2015 Jun 11. Br J Cancer. 2015. PMID: 26068398 Free PMC article.

2

Screening for colorectal cancer.

Van Cutsem E, Tejpar S, Rutgeerts P, Janssens J. Van Cutsem E, et al. Acta Gastroenterol Belg. 1995 Sep-Dec;58(5-6):397-404. Acta Gastroenterol Belg. 1995. PMID: 8775996

3

Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).

Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ, Alman BA. Tejpar S, et al. Among authors: van cutsem e. Br J Cancer. 2001 Jul 6;85(1):98-101. doi: 10.1054/bjoc.2001.1857. Br J Cancer. 2001. PMID: 11437409 Free PMC article.

4

The molecular basis of colorectal cancer.

Tejpar S, Cassiman JJ, Van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Acta Gastroenterol Belg. 2001 Jul-Sep;64(3):249-54. Acta Gastroenterol Belg. 2001. PMID: 11680042 Review.

5

Molecular and genetic defects in colorectal tumorigenesis.

Tejpar S, Van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):171-85. doi: 10.1053/bega.2001.0279. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969232 Review.

6

Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD).

Michils G, Tejpar S, Fryns JP, Legius E, Van Cutsem E, Cassiman JJ, Matthijs G. Michils G, et al. Among authors: van cutsem e. Eur J Hum Genet. 2002 Sep;10(9):505-10. doi: 10.1038/sj.ejhg.5200825. Eur J Hum Genet. 2002. PMID: 12173026

7

Molecular defects in colorectal tumorigenesis.

Tejpar S, van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Drugs Today (Barc). 2003;39 Suppl C:111-8. Drugs Today (Barc). 2003. PMID: 14988749 Review.

8

Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study.

Michils G, Tejpar S, Thoelen R, van Cutsem E, Vermeesch JR, Fryns JP, Legius E, Matthijs G. Michils G, et al. Among authors: van cutsem e. Hum Mutat. 2005 Feb;25(2):125-34. doi: 10.1002/humu.20122. Hum Mutat. 2005. PMID: 15643602

9

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

Van Cutsem E, Verslype C, Tejpar S. Van Cutsem E, et al. Semin Oncol. 2005 Feb;32(1):43-51. doi: 10.1053/j.seminoncol.2004.09.028. Semin Oncol. 2005. PMID: 15726505 Review.

10

Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients.

Spaepen M, Vankeirsbilck B, Van Opstal S, Tejpar S, Van Cutsem E, Geboes K, Legius E, Matthijs G. Spaepen M, et al. Among authors: van cutsem e, van opstal s. Fam Cancer. 2006;5(2):179-89. doi: 10.1007/s10689-005-5958-6. Fam Cancer. 2006. PMID: 16736289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page